Eli Lilly shells out US$4.5 billion for new drug development plant
ELI Lilly is pouring US$4.5 billion into a new manufacturing plant in Indiana to make drugs for future clinical trials, ...
ELI Lilly is pouring US$4.5 billion into a new manufacturing plant in Indiana to make drugs for future clinical trials, ...
SHELL has emerged as the lead bidder to buy assets of trading firm Pavilion Energy, in a deal that will ...
A GROUP including commodity trader Glencore and Indonesian chemicals business Chandra Asri Pacific is in advanced talks to buy Shell ...
SHELL’S United States solar business Savion has put around a quarter of its assets up for sale, according to a ...
NEARLY a third of Shell’s profit in the fourth quarter of 2023 came from the US$2.4 billion it made in ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2025 Forbes 40under40. All Rights Reserved.